Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
David Choi(Stanford University), James J. Mulé(Moffitt Cancer Center), M. Perrin(University of Michigan), Alfred E. Chang(University of Michigan), Joseph P. Uberti(Sheba Medical Center), Sandra Hoffmann(Economic Research Service), Kevin T. McDonagh(University of Michigan), Voravit Ratanatharathorn(University of Michigan–Ann Arbor)
PubMed
November 1, 1998
Cited by 28
Related Papers
Annual Cost of Illness and Quality-Adjusted Life Year Losses in the United States Due to 14 Foodborne Pathogens
|Journal of Food Protection|2012|609
Ranking the Disease Burden of 14 Pathogens in Food Sources in the United States Using Attribution Data from Outbreak Investigations and Expert Elicitation
|Journal of Food Protection|2012|541